Safety and Efficacy of CRD007 in Adult Asthma Subjects

PHASE2CompletedINTERVENTIONAL
Enrollment

168

Participants

Timeline

Start Date

November 30, 2015

Primary Completion Date

February 21, 2017

Study Completion Date

February 24, 2017

Conditions
Asthma
Interventions
DRUG

CRD007

DRUG

Placebo

Trial Locations (24)

1000

First MHAT - Sofia EAD, Third Department of Internal Medicine, Sofia

1336

MHAT Lyulin EAD, Department of Internal Medicine, Sofia

2400

Bisbebjerg Hospital, København NV

2600

MHAT St. Ivan Rilski-2003 Ltd., Department of Internal Medicine, Dupnitsa

2650

Hvidovre Hospital, Hvidovre

3000

SHATPPD Vratsa Ltd, Department of Pneumology, Vratsa

4400

SHATPPD - Pazardzhik EOOD, Department of phthisiatrics pneumonia and pulmonary functional diagnostics, Pazardzhik

4700

Medical Center Smolyan OOD, Office of Clinical Allergology, Smolyan

Næstved Sygehus, Lungemedinsk afdeling, Næstved

7200

Medical Center - Razgrad OOD, Office of Pneumonology and Phthisiatry, Razgrad

8600

Regionshospitalet Silkeborg, Silkeborg

9000

Aalborg Universitetshospital, Aalborg

80-546

Centrum Badań Klinicznych PI-House Sp. Z O.O., Gdansk

40-954

Medica Pro Familia, Katowice

31-637

NZOZ Centrum Medcyczne ProMiMed, Krakow

30-002

Medica Pro Familia, Krákow

20-045

Clinical Best Solution, Lublin

60-823

NZOZ ALERGO-MED. Specjalistyczna Przychodnia Lekarska, Poznan

01-868

Medica Pro Familia, Warsaw

52-416

Centrum Medyczne Oporów, Wroclaw

M23 9QZ

The Medicines Evaluation Unit (MEU) Ltd, Manchester

HA6 2RN

Medinova North London Clinical Studies Center, Northwood

RM1 3LT

Medinova East London Clinical Studies Centre, Romford

DA14 6LT

Medinova South London Clinical Studies Centre, Sidcup

All Listed Sponsors
lead

RSPR Pharma AB

INDUSTRY

NCT02615080 - Safety and Efficacy of CRD007 in Adult Asthma Subjects | Biotech Hunter | Biotech Hunter